Published in Skin Therapy Lett on September 01, 2008
The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int (2014) 1.86
Evaluation of the therapeutic effects of Aloe vera gel on minor recurrent aphthous stomatitis. Dent Res J (Isfahan) (2012) 0.96
Recurrent aphthous stomatitis. Dent Clin North Am (2014) 0.85
Regression of major recurrent aphthous ulcerations using a combination of intralesional corticosteroids and levamisole: a case report. Clinics (Sao Paulo) (2010) 0.83
Remission of severe aphthous stomatitis of celiac disease with etanercept. Clin Mol Allergy (2013) 0.76
Salivary Alpha-Amylase Enzyme, Psychological Disorders, and Life Quality in Patients with Recurrent Aphthous Stomatitis. Int J Dent (2017) 0.75
The Efficacy of Sucralfate and Chlorhexidine as an Oral Rinse in Patients with Recurrent Aphthous Stomatitis. Adv Med (2014) 0.75
Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check. J Clin Diagn Res (2016) 0.75
The safety and efficacy of AphtoFix® mouth ulcer cream in the management of recurrent aphthous stomatitis. BMC Oral Health (2016) 0.75
The therapeutic effects of chamomilla tincture mouthwash on oral aphthae: A Randomized Clinical Trial. J Clin Exp Dent (2014) 0.75
A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol (2006) 1.78
What is the pathogenesis of acne? Exp Dermatol (2005) 1.40
European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40
Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Br J Dermatol (2014) 1.39
[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38
Current use and future potential role of retinoids in dermatology. Drugs (1997) 1.35
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Generalized lichen nitidus. J Am Acad Dermatol (1997) 1.19
Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci (2007) 1.18
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol (1995) 1.16
Vitamins as hormones. Horm Metab Res (2007) 1.14
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol (2012) 1.06
Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02
Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol (2007) 1.01
Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res (1999) 0.99
Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol (2013) 0.99
An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol (2012) 0.98
Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol (2008) 0.96
Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol (2007) 0.96
[Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data]. Ophthalmologe (2012) 0.93
Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol (1992) 0.93
What causes hidradenitis suppurativa? Exp Dermatol (2008) 0.92
Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol (2009) 0.90
Is acne vulgaris a genuine inflammatory disease? Dermatology (2001) 0.90
Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology (1999) 0.90
Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res (2007) 0.89
Superimposed primary chancre in a patient with Adamantiades-Behçet's disease. Sex Transm Infect (1999) 0.89
Oral retinoids in the treatment of seborrhoea and acne. Dermatology (1998) 0.88
A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro. Mol Biol Rep (1994) 0.88
Pathogenesis and pathogenesis related treatment of acne. J Dermatol (1991) 0.88
[Interferon-alpha-induced psoriasis vulgaris]. Hautarzt (1996) 0.87
Effect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cells. Skin Pharmacol Physiol (2006) 0.87
The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology (1996) 0.87
Influence of physiological androgen levels on wound healing and immune status in men. Aging Male (2006) 0.86
Effect of skin surface temperature on skin pigmentation during contact and intralesional cryosurgery of keloids. J Eur Acad Dermatol Venereol (2007) 0.86
Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study. Dermatology (2000) 0.86
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol (2010) 0.85
Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis. Br J Dermatol (2014) 0.85
Nuclear hormone receptors in human skin. Horm Metab Res (2007) 0.85
A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication. Gene Ther (2003) 0.85
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84
Merkel cell carcinoma: report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivity. J Am Acad Dermatol (1997) 0.84
Recalcitrant severe erosive cutaneous lichen planus treated with extracorporeal photopheresis monotherapy. Br J Dermatol (2011) 0.83
Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells--evidence of its presence in melanocytes. J Invest Dermatol (1998) 0.83
Keratosis pilaris/ulerythema ophryogenes and 18p deletion: is it possible that the LAMA1 gene is involved? J Med Genet (2001) 0.83
Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol (1999) 0.83
All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Horm Metab Res (2007) 0.83
Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol (2006) 0.82
Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology (1998) 0.81
Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology (2001) 0.81
The SAHA syndrome. Horm Res (2000) 0.81
Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. Expert Opin Pharmacother (2008) 0.81
Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology (2000) 0.81
Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro. J Invest Dermatol (1993) 0.81
Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm Metab Res (2007) 0.80
Remission of scleromyxoedema following treatment with extracorporeal photopheresis. Br J Dermatol (1996) 0.80
Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne. J Eur Acad Dermatol Venereol (2006) 0.80
Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease. Eye (Lond) (2008) 0.80
Sebaceous cells in monolayer culture. In Vitro Cell Dev Biol (1993) 0.79
Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation? Dermatology (2011) 0.79
Epidermodysplasia verruciformis associated with neurofibromatosis type 1: coincidental association or model for understanding the underlying mechanism of the disease? Br J Dermatol (2002) 0.79
Corticotropin releasing hormone and its function in the skin. Horm Metab Res (2007) 0.79
[Epidemiology of ocular involvement in Adamantiades-Behçets disease]. Ophthalmologe (2012) 0.78
Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid. Arch Dermatol Res (2000) 0.78
Human sebocytes express prostaglandin E2 receptors EP2 and EP4 but treatment with prostaglandin E2 does not affect testosterone production. Br J Dermatol (2009) 0.78
Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro. Horm Metab Res (2007) 0.78
Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma. J Eur Acad Dermatol Venereol (2007) 0.78
Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne? Br J Dermatol (2010) 0.78
Endocrinology of the skin--a promising joint adventure. Horm Metab Res (2007) 0.78
IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. Clin Exp Rheumatol (2008) 0.78
[Juvenile Adamantiades-Behçet disease in decreased stimulation with anti-CD3 monoclonal antibody]. Hautarzt (1997) 0.77
Intestinal vasculitis in Adamantiades-Behçet disease presenting as acute abdomen. J Eur Acad Dermatol Venereol (2009) 0.77
Early descriptions of Adamantiades-Behçet's disease. Ann Rheum Dis (2003) 0.77
[Skin diseases in geriatric patients. Epidemiologic data]. Hautarzt (2012) 0.76
Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet disease. Arch Dermatol (1996) 0.76
[Dermatoendocrinology. Skin aging]. Hautarzt (2010) 0.76
Distant cutaneous manifestation of Crohn's disease presenting as a granulomatous erysipelas-like lesion. J Eur Acad Dermatol Venereol (1999) 0.76
Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells. Horm Res (2000) 0.76
Heterogeneity and quantitative differences of type 1 5 alpha-reductase expression in cultured skin epithelial cells. Dermatology (1998) 0.76
[Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome]. Dtsch Med Wochenschr (1998) 0.76
Is nerve growth factor a serum marker for neurological and psychiatric complications in Behcet's disease? Lancet (1996) 0.76
[Pseudo-scabies transmitted by red fox]. Hautarzt (1999) 0.75
Adamantiades-Behçet's disease with inner ear involvement. Clin Exp Rheumatol (2002) 0.75
Essential thrombocythemia and idiopathic cold agglutinin disease: two additional disorders associated with intravascular coagulation necrosis of the skin. J Am Acad Dermatol (1992) 0.75
Regression of multiple viral warts in a human immunodeficiency virus-infected patient treated by triple antiretroviral therapy. Br J Dermatol (2002) 0.75
11β-hydroxysteroid dehydrogenase type 1 is expressed in human sebaceous glands and regulates glucocorticoid-induced lipid synthesis and toll-like receptor 2 expression in SZ95 sebocytes. Br J Dermatol (2013) 0.75
Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities. Br J Dermatol (2014) 0.75
Successful treatment of solar lentigines by brief gentle cryosurgery using a Kryomed device. Br J Dermatol (2000) 0.75
Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events. J Eur Acad Dermatol Venereol (2013) 0.75
[Manifestation of epidermolysis bullosa acquisita (EBA) in the ENT area]. HNO (1999) 0.75
Rheumatoid nodules developing under methotrexate treatment for rheumatoid arthritis. Acta Derm Venereol (1999) 0.75
[Radiation-induced acne]. Hautarzt (2000) 0.75
[Schonlein-Henoch purpura associated with hepatitis B in a patient with HIV infection]. Dtsch Med Wochenschr (2001) 0.75
[Exfoliatio areata linguae et mucosae oris: a mucous membrane manifestation of psoriasis pustulosa?]. Hautarzt (1998) 0.75
Treatment of solar lentigo with cryosurgery. Acta Derm Venereol (1999) 0.75
Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients. Br J Dermatol (2005) 0.75
[Anti-oncogram-oriented polychemotherapy in metastasizing squamous cell carcinoma of the skin: impressive partial remission]. Hautarzt (1990) 0.75